Nanoceria Suppresses Multiple Low Doses of Streptozotocin-Induced Type 1 Diabetes by Inhibition of Nrf2/NF-κB Pathway and Reduction of Apoptosis

Abstract

Considered together, our data establishes the antidiabetic potential of NC which may become a novel strategy to combat T1DM in the near future.